The role of genetic variants of the dopaminergic system in heroin dependence;A dopaminerg rendszer genetikai polimorfizmusainak szerepe heroinfüggésben

Neuropsychopharmacologia Hungarica

Volumn 11, Issue 2, 2009, Pages 95-101

  Vereczkei, Andrea ^a   Sasvári Székely, Mária ^a   Barta, Csaba ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Addiction; Association; Candidate gene; COMT; DAT; Dopamine; Heroin dependence; Reward system

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER;

ARTICLE; DOPAMINERGIC SYSTEM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEROIN DEPENDENCE; HUMAN; MUTATIONAL ANALYSIS; PATHOGENESIS; PROTEIN FUNCTION; RISK FACTOR;

ANIMALS; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEROIN DEPENDENCE; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 68349110531     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Anokhin AP, Todorov AA, Madden PA, Grant JD, Heath AC (1999) Brain event-related potentials, dopamine D2 receptor gene polymorphism, and smoking. Genet Epidemiol 17, 37-42
2. Bierut LJ, Rice JP, Edenberg HJ, Goate A, Foroud T, Cloninger CR et al (2000) Family-based study of the association of the dopamine D2 receptor gene (DRD2) with habitual smoking. Am J Med Genet 90, 299-302
3. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH and Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263, 2055-2060
4. Bontempi S, Fiorentini C, Busi C, Guerra N, Spano P, Missale C (2007) Identification and characterization of two nuclear factorkappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology 148, 2563-2570
5. Cinciripini P, Wetter D, Tomlinson G, Tsoh J, De Moor C, Cinciripini L et al (2004) The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood. Nicotine Tob Res 6, 229-239
6. Cloninger CR (1991) D2 dopamine receptor gene is associated but not linked with alcoholism. JAMA 266(13), 1833-1834
7. Comings DE, Blum K (2000) Prog Brain Res. 126, 325-41
8. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D (1996) The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 6, 73-79
9. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbäumer K, Kung HF, Hahn K, Tatsch K (2000) Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. 27, 1518-1524
10. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH (2004) Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. Pharmacogenomics J 4, 102-109
11. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW (1999) Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Annals of the New York Academy of Sciences 877, 412-38
12. Fiorentini C, Guerra N, Facchetti M, Finardi A, Tiberio L, Schiaffonati L (2002) Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Mol Endocrinol 16, 353-366
13. Gelernter J, Goldman D, Risch N (1993) The A1 allele at the D2 dopamine receptor gene and alcoholism: A reappraisal. JAMA 269(13), 1673-1677
14. Gelernter J, Kranzler H (1999) D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology 20, 640-649
15. Gelernter J, Kranzler H, Satel S (1999) No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European and African Americans. Biol. Psychiatry 45, 340-345
16. Gelernter J, O'Malley S, Risch N, Kranzler H, Krystal J, Merikangas K, Kennedy J, Kidd KK (1991) No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 266, 1801-1807
17. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang B, Kranzler HR, Farrer L (2006) Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Human Molecular Genetics 15(24), 3498-3507
18. Gerra G, Garofano L, Pellegrini C, Bosari S, Zaimovic A, Moi G, Avanzini P, Talarico E, Gardini F, Donnini C (2005) Allelic association of a dopamine transporter gene polymorphism with antisocial behaviour in heroin-dependent patients. Addiction Biology 3, 275-81
19. Gerra G, Garofano L, Pellegrini C, Bosari S, Zaimovic A, Moi G, Avanzini P, Talarico E, Gardini F, Donnini C (2006) A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. PNAS 103, 4552-4557
20. Horowitz R, Kotler M, Shufman E, Aharoni S, Kremer I, Cohen H, Ebstein RP. (2000). Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. American Journal of Medical Genetics 96(5), 599-603
21. Hosak, L. (2007). Role of the COMT gene Val158Met polymorphism in mental disorders: a review. European Psychiatry 22(5), 276-281
22. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD (2009) Significant Association of ANKK1 and Detection of a Functional Polymorphism with Nicotine Dependence in an African-American Sample Neuropsychopharmacology 34, 319-330
23. Johnstone EC, Yudkin P, Griffiths SE, Fuller A, Murphy M, Walton R (2004) The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. Addict Biol 9, 221-226
24. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP. (1999). Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. American Journal of Medical Genetics 88(6), 628-633
25. Laruelle M, Gelernter J, Innis RB (1998) D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Molec. Psychiat. 3, 261-265
26. Lawford BR, Young RM, Noble EP, Sargent J, Rowell J, Shadforth S, Zhang X, Ritchie T (2000) The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet. 96(5), 592-8
27. Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W, Sham PC, Loh el-W, Murray RM, Collier DA. (2004). Association analysis of the DRD4 and COMT genes in methamphetamine abuse. American Journal of Medical Genetics Part B 129B(1), 120-124
28. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettini WH. (2008). Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology 33(13), 3078-3084
29. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298, 1912-1934
30. Mannisto, PT, Kaakkola, S (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviwes 51(4), 593-628
31. Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30, 151-159
32. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78, 189-225
33. Neville MJ, Johnstone EC, Walton RT, (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. 23(6), 540-5
34. Noble EP (1998) The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol 16(1), 33-45
35. Noble EP (2000) Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: A review. European Psychiatry: The Journal of the Association of European Psychiatrists 15(2), 79-89
36. Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. American Journal of Medical Genetics 116B(1), 103-125
37. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48, 648-654
38. Oosterhuis BE, LaForge KS, Proudnikov D, Ho A, Nielsen DA, Gianotti R, Barral S, Gordon D, Leal SM, Ott J, Kreek MJ. (2008). Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. American Journal of Medical Genetics Part B 147B(6), 793-798
39. Pato CN, Macciardi F, Pato MT, Verga M, Kennedy JL (1993) Review of the putative association of dopamine D2 receptor and alcoholism: A meta-analysis. American Journal of Medical Genetics 48(2), 78-82
40. Perez de los Cobos J, Baiget M, Trujols J, Sinol N, Volpini V, Banuls E, Calafell F, Luquero E, del Rio E, Alvarez E (2007) Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. Behavioral and Brain Functions 3, 25
41. Singleton AB, Thomson JH, Morris CM, Court JA, Lloyd S, Cholerton S (1998) Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics 8, 125-128
42. Strous, R. D., Nolan, K. A., Lapidus, R., Diaz, L., Saito, T., & Lachman, H. M. (2003). Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. American Journal of Medical Genetics Part B 120B(1), 29-34
43. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA (1997) D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7, 479-484
44. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T, Komiyama T, Mitsushio H, Sano A, Tanabe H (1999) Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Molecular Psychiatry 4, 552-557
45. Uhl G, Blum K, Noble E, Smith S (1993) Substance abuse vulnerability and D2 receptor genes. Trends in Neurosciences 16(3), 83-88
46. Uhl GR, Liu QR, Naiman D (2002) Substance abuse vulnerability loci: converging genome scanning data. Trends Genet 18, 420-5
47. Vandenbergh, D. J., Rodriguez, L. A., Miller, I. T., Uhl, G. R., & Lachman, H. M. (1997). High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. American Journal of Medical Genetics 74(4), 439-442
48. Xu K, Lichtermann D, Lipsky RH, Franke P, Liu X, Hu Y, Cao L, Schwab SG, Wildenauer DB, Bau CH (2004) Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 61, 597-606
49. Yang B, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2007) Association of haplotypic variants in DRD2, ANKK1,TTC12 and NCAM1 to alcohol dependence in independent case-control and family samples. Human Molecular Genetics 16, 2844-2853
50. Yang B, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2004) Advances in molecular genetics and the prevention and treatment of substance misuse: Implications of association studies of the A1 allele of the D2 dopamine receptor gene. Addictive Behaviors 29, 1275-1294